Viewing Study NCT05028556


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2025-12-25 @ 9:09 PM
Study NCT ID: NCT05028556
Status: COMPLETED
Last Update Posted: 2025-07-20
First Post: 2021-08-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial of Y101D, a PD-L1/TGF-β Bispecific Antibody, in Patients With Metastatic or Locally Advanced Solid Tumors
Sponsor: Wuhan YZY Biopharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module